A rating of 42 puts Salarius Pharmaceuticals Inc (SLRX) near the middle of the Biotechnology industry according to InvestorsObserver. Salarius Pharmaceuticals Inc's score of 42 means it scores higher than 42% of stocks in the industry. Salarius Pharmaceuticals Inc also received an overall rating of 54, putting it above 54% of all stocks. Biotechnology is ranked 8 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Salarius Pharmaceuticals Inc Stock Today?
Salarius Pharmaceuticals Inc (SLRX) stock is lower by -2.42% while the S&P 500 is up 0.13% as of 2:11 PM on Thursday, May 21. SLRX is lower by -$0.03 from the previous closing price of $1.24 on volume of 534,846 shares. Over the past year the S&P 500 is up 4.17% while SLRX is lower by -88.13%. SLRX lost -$1.50 per share the over the last 12 months.
